Phoenix PharmaLabs

Deal to Watch
BETA

Phoenix PharmaLabs is addressing the opioid crisis by developing a potent, safe, non-addictive painkiller.

Analytics

Raised to Date: $1,102,553

Aggregate Commitments $
Platform

Netcapital

Start Date

10/15/2018

Close Date

03/30/2019

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$1

Security Type

Equity - Common

Funding Type

RegCF

Valuation

$23,136,335

Weekly Commitments $
Status
Funded
Reporting Date

03/31/2019

Days Remaining
Funded
% of Min. Goal

11,026%

% of Max. Goal

103%

Likelihood of Max
Funded
Avg. Daily Raise

$6,642

Momentum
Funded

Phoenix PharmaLabs has created a safe and non-addictive painkiller that they hope will combat the opioid epidemic and crisis. This preclinical, potent treatment can be used for both pain and addiction treatment. So far, it’s been tested in animal studies to be effective, does not produce withdrawal, does not cause death from overdose, and does not cause constipation. The US Army and the NIH have already been provided a $3M grant, and with this campaign, Phoenix PharmaLabs hopes to accelerate the advancement of the drug and perform key studies in humans.

Research

Other Deals

Kiwibot on Wefunder

Kiwibot has been selected as a “Top Deal” by KingsCrowd. This distinction is reserved for deals selected into…

Crowd
Neighborhood Sun on Wefunder

The Neighborhood Sun team has been selected as a “Top Deal” by KingsCrowd. This distinction is reserved for…

Crowd
goDeskless on MicroVentures

The goDeskless team has been selected as a “Top Deal” by KingsCrowd. This distinction is reserved for deals…

Crowd
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Phoenix PharmaLabs
Follow company
Follow Phoenix PharmaLabs